CoChat

Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells

Open access
El Hallal, Ralph, Lyu, Nana, Wang, Yuling · 2021 · Molecules

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Epidermal growth factor receptor (EGFR) is estimated to be overexpressed in 60~80% of colorectal cancer (CRC), which is associated with a poor prognosis. Anti-EGFR targeted monoclonal antibodies (cetuximab and panitumumab) have played an important role in the treatment of metastatic CRC. However, the therapeutic response of anti-EGFR monoclonal antibodies is limited due to multiple resistance mechanisms. With the discovery of new functions for gold nanoparticles (AuNPs), we hypothesize that cetuximab-conjugated AuNPs (cetuximab-AuNPs) will not only improve the cytotoxicity for cancer cells, but also introduce expression change of the related biomarkers on cancer cell surface. In this contribution, we investigated the size-dependent cytotoxicity of cetuximab-AuNPs to CRC cell line (HT-29), while also monitored the expression of cell surface biomarkers in response to treatment with cetuximab and cetuximab-AuNPs. AuNPs with the size of 60 nm showed the highest impact for cell cytotoxicity, which was tested by cell counting kit-8 (CCK-8) assay. Three cell surface biomarkers including epithelial cell adhesion molecule (EpCAM), melanoma cell adhesion molecule (MCAM), and human epidermal growth factor receptor-3 (HER-3) were found to be expressed at higher heterogeneity when cetuximab was conjugated to AuNPs. Both surface-enhanced Raman scattering/spectroscopy (SERS) and flow cytometry demonstrated the correlation of cell surface biomarkers in response to the drug treatment. We thus believe this study provides powerful potential for drug-conjugated AuNPs to enhance cancer prognosis and therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules26030567

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of gold nanoparticles (AuNPs). (A) Transmission electron microscopy (TEM) images of AuNPs at sizes of 25, 40, 60, and 80 nm; (B) Normalized UV-Vis spectra of AuNPs at different sizes; (C) surface-enhanced Raman scattering/spectroscopy (SERS) spectra of Raman reporter 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) on AuNPs at different sizes (25, 40, 60, and 80 nm).
Figure 1 Characterization of gold nanoparticles (AuNPs). (A) Transmission electron microscopy (TEM) images of AuNPs at sizes of 25, 40, 60, and 80 nm; (B) Normalized UV-Vis spectra of AuNPs at different sizes; (C) surface-enhanced Raman scattering/spectroscopy (SERS) spectra of Raman reporter 5,5′-dithiobis-(2-nitrobenzoic acid) (DTNB) on AuNPs at different sizes (25, 40, 60, and 80 nm).CC BY · PubMed Central
Figure 2 Cytotoxicity study by CCK-8 assay for HT-29 cells treated with cetuximab, AuNPs and cetuximab-AuNPs with sizes of 25, 40, and 60 nm for 48 h. (A) Low concentration of cetuximab (5 µg/mL); (B) High concentration of cetuximab (10 µg/mL). The cells treated with phosphate buffered saline (PBS) only and with cetuximab only were shown as green bar and purple bar, respectively. Error bar represents standard deviation (SD) of 5 replicates in 96-well plate.
Figure 2 Cytotoxicity study by CCK-8 assay for HT-29 cells treated with cetuximab, AuNPs and cetuximab-AuNPs with sizes of 25, 40, and 60 nm for 48 h. (A) Low concentration of cetuximab (5 µg/mL); (B) High concentration of cetuximab (10 µg/mL). The cells treated with phosphate buffered saline (PBS) only and with cetuximab only were shown as green bar and purple bar, respectively. Error bar represents standard deviation (SD) of 5 replicates in 96-well plate.CC BY · PubMed Central
Figure 3 (A) SERS spectra of individual SERS nanotags; (B) SERS spectra of 3-plex SERS nanotags. The arrows indicate the characteristic peak of each nanotag for detecting the corresponding biomarker.
Figure 3 (A) SERS spectra of individual SERS nanotags; (B) SERS spectra of 3-plex SERS nanotags. The arrows indicate the characteristic peak of each nanotag for detecting the corresponding biomarker.CC BY · PubMed Central
Figure 4 Phenotyping of the cell surface biomarkers. (A) Raman signal frequency distribution and (B) flow cytometry for cell surface markers (EpCAM, MCAM, and HER3) before drug treatment.
Figure 4 Phenotyping of the cell surface biomarkers. (A) Raman signal frequency distribution and (B) flow cytometry for cell surface markers (EpCAM, MCAM, and HER3) before drug treatment.CC BY · PubMed Central
Figure 5 The evolution of surface marker expression after treating with cetuximab and cetuximab-AuNPs. Raman signal intensity distribution for cell surface markers EpCAM (A), MCAM (B), and HER3 (C).
Figure 5 The evolution of surface marker expression after treating with cetuximab and cetuximab-AuNPs. Raman signal intensity distribution for cell surface markers EpCAM (A), MCAM (B), and HER3 (C).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 51

Metadata

Authors
El Hallal, R., Lyu, N., & Wang, Y.
Affiliations
  • Department of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia
  • Macquarie University (AU)
Corresponding author
Wang, Yuling
Venue
Molecules
Publisher
MDPI AG
Published
2021-01-22
Volume
26
Issue
3
Pages
567
ISSN
1420-3049 (ISSN-L)
OpenAlex
W3121829375
Cited by
51
References
76
Citations by year
2026: 5 · 2025: 9 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 2
FWCI
2.25
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Cancer Institute NSW
Topics
  • Physical Sciences › Materials Science › Electronic, Optical and Magnetic Materials › Gold and Silver Nanoparticles Synthesis and Applications
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
cetuximab, gold nanoparticles, colorectal cancer, epidermal growth factor receptor, cytotoxicity, nanoparticle size, cell surface markers, EpCAM, CD146, HER3, HT-29 cells, surface-enhanced Raman scattering, targeted cancer therapy
MeSH terms
Cetuximab, Epithelial Cell Adhesion Molecule, Antineoplastic Agents, Immunological, Cell Survival, Gold, Humans, Particle Size, Phenotype, Spectrum Analysis, Raman, Biomarkers, Tumor, Colorectal Neoplasms, Signal Transduction, HT29 Cells, Receptor, ErbB-3, CD146 Antigen, Metal Nanoparticles, Nanoconjugates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells. https://app.cochat.ai/papers/10.3390/molecules26030567
The paper
El Hallal, R., Lyu, N., & Wang, Y. (2021). Effect of Cetuximab-Conjugated Gold Nanoparticles on the Cytotoxicity and Phenotypic Evolution of Colorectal Cancer Cells. Molecules. https://doi.org/10.3390/molecules26030567

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.